Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis
중증 코로나19 환자의 인터루킨-6: 후향적 분석
Clinical Trial
[키워드] Admission
admitted patients
AUROC
Blood
Blood cells
blood concentration
C-reactive protein
China
clinician
collected
Concentration
conducted
coronavirus disease
Coronavirus disease 2019
Course
COVID-19
COVID-19 patient
Critically ill
critically ill COVID-19 patients
cytokine
Cytokine storm
D-dimers
demographic
diagnosis of COVID-19
disease
evaluate
ferritin
help
highest
ICU
IL-6
IL-6 level
intensive care unit
interleukin-6
Interleukine-6
laboratory data
Lactate
lactate dehydrogenase
LDH
lymphocyte
Lymphocytes
Mortality
non-survivor
outcome
parameter
pathophysiology
Patient
patients
patients with COVID-19
poor prognosis
Predictive
Predictive value
repeated
Result
Retrospective analysis
Retrospective study
risk
severity
significant difference
significantly higher
Spread
survivor
White blood cell
White blood cells
[DOI] 10.1371/journal.pone.0244628 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1371/journal.pone.0244628 PMC 바로가기 [Article Type] Clinical Trial